loading

Arrivent Biopharma Inc Borsa (AVBP) Ultime notizie

pulisher
Nov 22, 2025

Avoiding Lag: Real-Time Signals in (AVBP) Movement - news.stocktradersdaily.com

Nov 22, 2025
pulisher
Nov 21, 2025

ArriVent Maps Ambitious 2026 Oncology Push as Firmonertinib Program Gains Steam - MSN

Nov 21, 2025
pulisher
Nov 20, 2025

Is ArriVent BioPharma Inc. stock in correction or buying zoneCEO Change & Smart Money Movement Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Can ArriVent BioPharma Inc. stock outperform in 2025 bull marketEarnings Overview Summary & Momentum Based Trading Signals - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Best data tools to analyze ArriVent BioPharma Inc. stockJuly 2025 Big Picture & Smart Swing Trading Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How institutional ownership impacts ArriVent BioPharma Inc. stockWeekly Trade Recap & Stepwise Entry and Exit Trade Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will ArriVent BioPharma Inc. stock gain from lower inflationWeekly Profit Recap & Reliable Volume Spike Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How ArriVent BioPharma Inc. stock reacts to Fed rate cutsGap Down & High Yield Equity Trading Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can momentum traders help lift ArriVent BioPharma Inc.Portfolio Value Summary & AI Forecasted Stock Moves - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 02:02:03 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is ArriVent BioPharma Inc. stock a defensive play in 20252025 Volatility Report & Real-Time Chart Pattern Alerts - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Why Red River Bancshares, Inc. stock attracts strong analyst attention - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Evaluating ArriVent BioPharma Inc. with trendline analysisWeekly Risk Summary & Free Real-Time Market Sentiment Alerts - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Analyzing ArriVent BioPharma Inc. with risk reward ratio chartsJuly 2025 Decliners & Growth Oriented Trading Recommendations - newser.com

Nov 18, 2025
pulisher
Nov 15, 2025

Published on: 2025-11-15 15:01:05 - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

Why ArriVent BioPharma Inc. stock is favored by pension fundsLong Setup & Accurate Entry/Exit Alerts - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Momentum divergence signals in ArriVent BioPharma Inc. chartWeekly Stock Recap & Real-Time Volume Analysis - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

What is the fair value of ArriVent BioPharma Inc. stock now2025 Earnings Impact & Fast Gain Stock Tips - Fundação Cultural do Pará

Nov 14, 2025
pulisher
Nov 14, 2025

What is HC Wainwright’s Forecast for AVBP FY2025 Earnings? - Defense World

Nov 14, 2025
pulisher
Nov 12, 2025

We Think ArriVent BioPharma (NASDAQ:AVBP) Needs To Drive Business Growth Carefully - Yahoo Finance

Nov 12, 2025
pulisher
Nov 12, 2025

Real time pattern detection on ArriVent BioPharma Inc. stockWeekly Trade Recap & Pattern Based Trade Signal System - newser.com

Nov 12, 2025
pulisher
Nov 11, 2025

ArriVent BioPharma, Inc.: Strategic Advancements and Promising Developments Drive Buy Rating with $45 Price Target - TipRanks

Nov 11, 2025
pulisher
Nov 11, 2025

ArriVent Biopharma : Corporate Presentation November 2025 - MarketScreener

Nov 11, 2025
pulisher
Nov 11, 2025

ArriVent BioPharma’s Promising Trial Results and Strategic Developments Drive Buy Rating - TipRanks

Nov 11, 2025
pulisher
Nov 11, 2025

Discipline and Rules-Based Execution in AVBP Response - news.stocktradersdaily.com

Nov 11, 2025
pulisher
Nov 10, 2025

ArriVent BioPharma Reports Q3 2025 Financial Results - TipRanks

Nov 10, 2025
pulisher
Nov 10, 2025

ArriVent BioPharma Reports Third Quarter 2025 Financial Results - The Globe and Mail

Nov 10, 2025
pulisher
Nov 10, 2025

ArriVent BioPharma stock price target raised to $47 from $32 at Clear Street - Investing.com Canada

Nov 10, 2025
$38.92
price up icon 1.38%
$30.45
price up icon 1.36%
$102.06
price up icon 0.29%
$95.59
price down icon 1.42%
biotechnology ONC
$347.72
price down icon 0.45%
$198.76
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):